These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23705810)

  • 21. In vitro toxicity: mechanisms, alternatives and validation - a report from the 19th annual scientific meeting of the Scandinavian Society for Cell Toxicology.
    Forsby A
    Altern Lab Anim; 2002; 30(3):307-8. PubMed ID: 12106008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational chemistry, systems biology and toxicology. Harnessing the chemistry of life: revolutionizing toxicology. a commentary.
    Kimber I; Humphris C; Westmoreland C; Alepee N; Negro GD; Manou I
    J Appl Toxicol; 2011 Apr; 31(3):206-9. PubMed ID: 21404310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
    Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
    Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regenerative toxicology: the role of stem cells in the development of chronic toxicities.
    Canovas-Jorda D; Louisse J; Pistollato F; Zagoura D; Bremer S
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):39-50. PubMed ID: 24102433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FutureTox II: in vitro data and in silico models for predictive toxicology.
    Knudsen TB; Keller DA; Sander M; Carney EW; Doerrer NG; Eaton DL; Fitzpatrick SC; Hastings KL; Mendrick DL; Tice RR; Watkins PB; Whelan M
    Toxicol Sci; 2015 Feb; 143(2):256-67. PubMed ID: 25628403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges of using pluripotent stem cells for safety assessments of substances.
    Vojnits K; Bremer S
    Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug safety testing paradigm, current progress and future challenges: an overview.
    Ahuja V; Sharma S
    J Appl Toxicol; 2014 Jun; 34(6):576-94. PubMed ID: 24777877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational toxicology at the European Commission's Joint Research Centre.
    Mostrag-Szlichtyng A; Zaldívar Comenges JM; Worth AP
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):785-92. PubMed ID: 20443752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The importance of standardised cell culture methods for the routine toxicology in pharmaceutical companies].
    Schmuck G
    ALTEX; 2001; 18(1):79-80. PubMed ID: 11248856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
    Trosko JE; Chang CC
    Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental toxicity testing from animal towards embryonic stem cells.
    Pellizzer C; Bremer S; Hartung T
    ALTEX; 2005; 22(2):47-57. PubMed ID: 15953962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models.
    Sukardi H; Chng HT; Chan EC; Gong Z; Lam SH
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):579-89. PubMed ID: 21345150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative animal models in predictive toxicology.
    Khabib MNH; Sivasanku Y; Lee HB; Kumar S; Kue CS
    Toxicology; 2022 Jan; 465():153053. PubMed ID: 34838596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do we need a "Chair of alternative methods", and where?
    Wendel A
    ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.